









Markets
/
Stocks
/
nasdaq-allr
/

Allarity Therapeutics Inc

ALLR

1.010USD

0.000

Market hours （ET）Quotes delayed by 15 min

17.19MMarket Cap

LossP/E TTM



Allarity Therapeutics Inc

1.010

0.000

Overview Company Financials

Overview

Company

Financials

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-91.99%-2.69M

-91.75%-3.21M

8.78%-5.44M

-189.10%-7.22M

56.29%-1.40M

31.64%-1.67M

-35.37%-5.97M

40.68%-2.50M

44.38%-3.20M

43.37%-2.45M

---4.41M

---4.21M

---5.75M

---4.32M

Net income from continuing operations

28.91%-2.73M

-332.81%-7.45M

-160.63%-11.59M

31.55%-1.63M

-14.65%-3.84M

39.32%-1.72M

11.71%-4.45M

53.36%-2.38M

-8.83%-3.35M

83.12%-2.84M

---5.04M

---5.10M

---3.08M

---16.82M

Operating gains losses

450.00%11.00K

-88.89%1.00K

107766.67%9.71M

-88.89%1.00K

-80.00%2.00K

-99.75%9.00K

-18.18%9.00K

-62.50%9.00K

-99.93%10.00K

22187.50%3.57M

--11.00K

--24.00K

--14.03M

--16.00K

Deferred tax

100.00%0.00

-100.00%0.00

---432.00K

--0.00

---14.00K

135.93%97.00K

100.00%0.00

-100.00%0.00

100.00%0.00

-114.29%-270.00K

---119.00K

--4.00K

---1.23M

---126.00K

Other non-cash items

84.21%-12.00K

56.55%-116.00K

-122.45%-33.00K

253.57%99.00K

12.64%-76.00K

46.06%-267.00K

137.40%147.00K

-97.41%28.00K

-134.12%-87.00K

-2162.50%-495.00K

---393.00K

--1.08M

--255.00K

--24.00K

Change in working capital

-105.16%-149.00K

12.31%3.91M

-73.79%-3.16M

-419.48%-3.58M

405.60%2.89M

273.58%3.48M

-403.68%-1.82M

70.32%1.12M

122.71%571.00K

-85.84%931.00K

--598.00K

--657.00K

---2.51M

--6.58M

-Change in receivables

33.14%-345.00K

17.91%882.00K

-508.33%-73.00K

66.44%-248.00K

-2143.48%-516.00K

-4.96%748.00K

93.81%-12.00K

-435.51%-739.00K

94.95%-23.00K

33.62%787.00K

---194.00K

---138.00K

---455.00K

--589.00K

-Change in prepaid expenses

-94.14%14.00K

7.53%-356.00K

222.16%215.00K

-53.32%176.00K

4083.33%239.00K

-231.90%-385.00K

-145.71%-176.00K

10.88%377.00K

99.51%-6.00K

-243.21%-116.00K

--385.00K

--340.00K

---1.23M

--81.00K

-Change in other current assets

-94.95%5.00K

-101.83%-15.00K

-94.42%31.00K

-200.00%-21.00K

621.05%99.00K

155.97%820.00K

1584.85%556.00K

93.91%-7.00K

-104.04%-19.00K

-528.76%-1.47M

--33.00K

---115.00K

--470.00K

---233.00K

-Change in other current liabilities

----

--207.00K

----

Cash from non-recurring investing activities

Cash from operating activities

-91.99%-2.69M

-91.75%-3.21M

8.78%-5.44M

-189.10%-7.22M

56.29%-1.40M

31.64%-1.67M

-35.37%-5.97M

40.68%-2.50M

44.38%-3.20M

43.37%-2.45M

---4.41M

---4.21M

---5.75M

---4.32M

Investing cash flow

Net cash from continuing investing activities

----

--298.00K

----

-100.00%0.00

--0.00

100.00%0.00

460.00%18.00K

--0.00

---809.00K

---5.00K

Capital expenditures

----

--298.00K

----

--18.00K

----

Net cash flow from disposal of fixed assets

----

--298.00K

----

-100.00%0.00

--0.00

100.00%0.00

460.00%18.00K

--0.00

---809.00K

---5.00K

Net cash flow from investment products

----

--591.00K

----

Cash from non-current investing activities

Net cash flow from investing activities

----

---298.00K

----

100.00%0.00

--591.00K

--0.00

-100.00%0.00

-460.00%-18.00K

--0.00

--809.00K

--5.00K

Financing cash flow

Cash flow from continuous financing activities

707.46%11.14M

711.30%4.24M

-24.53%4.87M

818.29%26.31M

19.17%1.38M

-47.80%522.00K

--6.45M

223.97%2.87M

--1.16M

-94.58%1.00M

--0.00

---2.31M

--0.00

--18.44M

Net cash flow from debt Issuance/repayment

-100.00%0.00

100.00%0.00

41.69%-1.34M

--1.34M

-100.10%-1.00K

---350.00K

---2.30M

----

732.91%1.00M

--0.00

---158.00K

Net cash flow from common stock issuance/repurchase

27757.50%11.14M

--4.24M

-46.13%5.43M

306.29%27.69M

-96.55%40.00K

--0.00

--10.08M

--6.81M

--1.16M

-100.00%0.00

--0.00

----

--17.25M

Net cash flow from preferred stock issuance/repurchase

----

--0.00

88.76%-562.00K

----

--0.00

---5.00M

-9.33%-1.65M

----

--0.00

---1.51M

----

--0.00

Proceeds from issuance of warrants

----

-100.00%0.00

----

--523.00K

--1.72M

----

-100.00%0.00

--0.00

----

--2.77M

Net cash flow from other financing activities

----

--0.00

----

---40.00K

100.00%0.00

--0.00

100.00%0.00

---2.00K

100.00%0.00

--0.00

---800.00K

----

---1.42M

Net cash from non-recurrent financing activities

Net cash from financing activities

707.46%11.14M

711.30%4.24M

-24.53%4.87M

818.29%26.31M

19.17%1.38M

-47.80%522.00K

--6.45M

223.97%2.87M

--1.16M

-94.58%1.00M

--0.00

---2.31M

--0.00

--18.44M

Net cash flow

Beginning cash balance

11666.87%19.53M

1219.73%18.46M

4479.29%19.23M

5.76%312.00K

-91.82%166.00K

-64.55%1.40M

-94.53%420.00K

-97.97%295.00K

-89.62%2.03M

-29.33%3.95M

--7.68M

--14.54M

--19.55M

--5.58M

Current period cash flow changes

5496.58%8.17M

186.78%1.07M

-178.65%-770.00K

15036.80%18.92M

108.42%146.00K

35.68%-1.23M

126.24%979.00K

101.82%125.00K

65.40%-1.73M

-113.72%-1.92M

---3.73M

---6.87M

---5.01M

--13.97M

Effect of exchange rate changes

-273.33%-286.00K

508.43%339.00K

-105.26%-195.00K

29.51%-172.00K

-46.60%165.00K

81.68%-83.00K

-114.03%-95.00K

29.89%-244.00K

575.38%309.00K

-198.03%-453.00K

--677.00K

---348.00K

---65.00K

---152.00K

Ending cash balance

8779.49%27.70M

11666.87%19.53M

1219.73%18.46M

4479.29%19.23M

5.76%312.00K

-91.82%166.00K

-64.55%1.40M

-94.53%420.00K

-97.97%295.00K

-89.62%2.03M

--3.95M

--7.68M

--14.54M

--19.55M

Free cash flow

----

-109.57%-3.50M

----

32.14%-1.67M

-35.37%-5.97M

40.68%-2.50M

44.38%-3.20M

42.95%-2.46M

---4.41M

---4.21M

---5.75M

---4.32M

Currency unit

USD

Audit opinions

KeyAI

